정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 863 | Completed | Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia | Fibrosis Lung | Drug: Treamid Drug: Placebo |
Phase 2 | PHARMENTERPRISES LLC | INDUSTRY | 60 | All | 18 Years ~ 75 Years | Federal State-Funded Research Institution "Research Institute of Complex Cardiovascular Diseases", Kemerovo, Russian Federation Federal State Budgetary Institution "N.N. Burdenko Military Clinical Hospital", Moscow, Russian Federation SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow, Russian Federation Moscow State Medical-Dentist University n.a. A.I. Evdokimov on basis of SMHI "City Hospital № 62", branch 5, Moscow, Russian Federation State Budgetary Health Institution "Republican Hospital named V.A.Baranov", Petrozavodsk, Russian Federation Federal State Budgetary Educational Institution of Higher Education "Rostov State Medical University", Rostov-on-Don, Russian Federation LLC "Medical Center "Reavita Med St. Petersburg", Saint Petersburg, Russian Federation State autonomous healthcare institution of Yaroslavl Region "Сlinical hospital for emergency medical care n. a. N.V. Solovyov", Yaroslavl, Russian Federation |
| 862 | Recruiting | Pilot Study to Detect SARS-CoV-2 Virus in Sperm | Covid19 | Biological: Sample | Not Applicable | University Hospital, Toulouse | OTHER | 50 | Male | 18 Years ~ 50 Years | University Hospital Toulouse, Toulouse, France |
| 861 | Recruiting | Pilot Trial of XFBD, a TCM, in Persons With COVID-19 | Covid19 | Drug: Xuanfei Baidu Granules Other: Placebo |
Phase 2 | Darcy Spicer | OTHER | 60 | All | 18 Years ~ 75 Years | University of Southern California, Los Angeles, California, United States |
| 860 | Recruiting | Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 | Fibrotic Pulmonary Sequelae Post-COVID19 Infection | Drug: Pirfenidone Drug: Placebo |
Phase 2 | Institut d'Investigacio Biomedica de Bellvitge | OTHER | 148 | All | 18 Years | University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain Hospital Germans Trias i Pujol, Badalona, Spain Hospital Clinic, Barcelona, Spain Hospital del Mar, Barcelona, Spain Hospital Sant Pau, Barcelona, Spain Hospital La Princes, Madrid, Spain Hospital Puerta de Hierro, Madrid, Spain Hospital Ramon y Cajal, Madrid, Spain |
| 859 | Recruiting | Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia | Novel Coronavirus-induced Lung Fibrosis | Drug: Pirfenidone Drug: Nintedanib |
Phase 4 | Postgraduate Institute of Medical Education and Research | OTHER_GOV | 48 | All | 18 Years | Postgraduate Institute of Medical Education and Research, Chandigarh, India |
| 858 | Completed | Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting | Corona Virus Infection | Dietary Supplement: Zinc Sulfate 220 MG Drug: Placebo |
Phase 4 | St. Francis Hospital, New York | OTHER | 3 | All | 30 Years | St. Francis Hospital - The Heart Center, Roslyn, New York, United States |
| 857 | Recruiting | Plant Stanol Esters and COVID-19 Vaccination Response | Overweight and Obesity | Dietary Supplement: Plant stanol mini drinks Dietary Supplement: Placebo mini drinks Biological: COVID-19 vaccine |
Not Applicable | Maastricht University Medical Center, Raisio Nutrition Ltd. | OTHER | 100 | All | 18 Years | Maastricht University Medical Center, Maastricht, Limburg, Netherlands |